133 related articles for article (PubMed ID: 3263388)
1. Disk diffusion interpretive criteria for extended-spectrum cephalosporins with Haemophilus influenzae.
Jorgensen JH; Maher LA; Redding JS
J Clin Microbiol; 1988 Sep; 26(9):1887-9. PubMed ID: 3263388
[TBL] [Abstract][Full Text] [Related]
2. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268
[TBL] [Abstract][Full Text] [Related]
3. Disk diffusion susceptibility testing of Haemophilus influenzae using haemophilus test medium.
Doern GV; Jorgensen JH; Thornsberry C; Snapper H
Eur J Clin Microbiol Infect Dis; 1990 May; 9(5):329-36. PubMed ID: 2373087
[TBL] [Abstract][Full Text] [Related]
4. Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Jones RN
J Clin Microbiol; 1990 Mar; 28(3):605-7. PubMed ID: 2182675
[TBL] [Abstract][Full Text] [Related]
5. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
Zerva L; Biedenbach DJ; Jones RN
J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
Fuchs PC; Barry AL; Brown SD
Diagn Microbiol Infect Dis; 2000 Aug; 37(4):265-9. PubMed ID: 10974578
[TBL] [Abstract][Full Text] [Related]
7. Effect of extended-spectrum beta-lactamases on the susceptibility of Haemophilus influenzae to cephalosporins.
Tristram SG
J Antimicrob Chemother; 2003 Jan; 51(1):39-43. PubMed ID: 12493785
[TBL] [Abstract][Full Text] [Related]
8. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050
[TBL] [Abstract][Full Text] [Related]
9. Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzae.
Barrett MS; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):462-5. PubMed ID: 1330563
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Haemophilus influenzae isolates with known resistance mechanisms to five cephalosporins.
Yeo SF; Chiew YF; Fung CP
Chemotherapy; 1996; 42(2):85-9. PubMed ID: 8697893
[TBL] [Abstract][Full Text] [Related]
11. Interpretive criteria for susceptibility tests with DU-6859a and FK-037 tested against Haemophilus influenzae and Neisseria gonorrhoeae.
Jones RN; Barrett MS; Biedenbach DJ
Diagn Microbiol Infect Dis; 1994 Jun; 19(2):93-9. PubMed ID: 7805362
[TBL] [Abstract][Full Text] [Related]
12. Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.
Bale MJ; Jones RN; Erwin ME; Koontz FP; Gerlach EH; Murray PR; Washington JA
J Clin Microbiol; 1992 Mar; 30(3):744-5. PubMed ID: 1313052
[TBL] [Abstract][Full Text] [Related]
13. Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium.
Doern GV; Gerlach EH; Jorgensen JH; Murray PR; Thornsberry C; Washington JA
Diagn Microbiol Infect Dis; 1991; 14(6):485-93. PubMed ID: 1802535
[TBL] [Abstract][Full Text] [Related]
14. Investigation of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines.
Heelan JS; Chesney D; Guadagno G
J Clin Microbiol; 1992 Jul; 30(7):1674-7. PubMed ID: 1629320
[TBL] [Abstract][Full Text] [Related]
15. Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.
Jorgensen JH; Barry AL; Doern GV; Ferraro MJ; Murray PR
J Clin Microbiol; 1992 Aug; 30(8):2029-32. PubMed ID: 1500510
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae.
Burns JL; Wong K; Smith AL
Infection; 1988; 16(5):293-6. PubMed ID: 3265130
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
Doern GV; Vautour R
Diagn Microbiol Infect Dis; 1992; 15(7):633-40. PubMed ID: 1424521
[TBL] [Abstract][Full Text] [Related]
18. Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.
Jones RN; Barry AL
J Clin Microbiol; 1988 Apr; 26(4):770-3. PubMed ID: 3259247
[TBL] [Abstract][Full Text] [Related]
19. Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium.
Pfaller MA; Jones RN; Washington JA; Koontz FP; Gerlach EH; Erwin ME
Diagn Microbiol Infect Dis; 1992 Feb; 15(2):145-50. PubMed ID: 1315231
[TBL] [Abstract][Full Text] [Related]
20. Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
Jones RN; Doern GV; Gerlach EH; Hindler J; Erwin ME
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):243-9. PubMed ID: 7924221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
